FundedIQ
Biotechnology

Auron Therapeutics: Funding, Investors & Team (Nov 2026)

Auron Therapeutics is to foster treatments to fix disease by drastically changing the worldview of malignant growth therapeutics from cell killing, to change of threatening cells into ordinary cells. This change, called separation treatment, reactivates endogenous cell projects to evoke growth cell development and the progress from disease to typical tissue. Its remarkable stages consider reconciliation of huge omic datasets and scaled down high throughput stream cytometry to recognize and approve numerous objectives and medications in essential human patient examples quickly.

aurontx.com LinkedIn Wellesley, United States 1-10 employees
Total raised
$87.8M
Rounds
3
Latest
Series B
Feb 2025

Auron Therapeutics has raised $87.8M across 3 funding rounds on record, the most recent a Series B of $27.0M announced in Feb 2025.

That round is above the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Auron Therapeutics Company Profile and Key Stats

Total funding raised
$87.8M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Series B
$27.0M in Feb 2025
Employees
1-10
reported band
Headquarters
Wellesley, United States

Latest funding round on record: Feb 2025.

Auron Therapeutics Funding Rounds

Date
Round
Amount
Series B
$27.0M
Series A
$48.0M
Seed
$12.8M

Auron Therapeutics raised $12.8M in a Seed announced in Jan 2021.

1.5 years later, a Series A of $48.0M was announced in Jul 2022.

2.6 years later, a Series B of $27.0M was announced in Feb 2025.

Auron Therapeutics Founders and Leadership Team

Name
Role
Contact
Kate Yen
Founder
Locked
Matthew Heiden
Founder
—

Contact details for the Auron Therapeutics team: 1 of 2 have an email address on file.

Start 14-day free trial →

Auron Therapeutics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.9M
30,615
$7.8M
4,483
$32M

Auron Therapeutics' latest round of $27.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Auron Therapeutics in Biotechnology and Wellesley

Companies Similar to Auron Therapeutics

Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…

Seed $4.5M

Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.

Pre-Seed $5.3M

Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…

Series B $25.0M

Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…

Undisclosed round $380k

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…

Series C $100M

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…

Series B $41.9M

Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…

Series A $6.0M

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…

Series D —

Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…

Undisclosed round $21.5M

100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…

Pre-Seed $110k

MEND is a company focused on life sciences, determined to assist individuals in achieving better health…

Undisclosed round $1.5M

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Auron Therapeutics Funding FAQs

What does Auron Therapeutics do?

Auron Therapeutics is to foster treatments to fix disease by drastically changing the worldview of malignant growth therapeutics from cell killing, to change of threatening cells into ordinary cells. This change, called separation treatment, reactivates endogenous cell projects to evoke growth cell development and the progress from disease to typical tissue. Its remarkable stages consider reconciliation of huge omic datasets and scaled down high throughput stream cytometry to recognize and approve numerous objectives and medications in essential human patient examples quickly.

How much funding has Auron Therapeutics raised?

Auron Therapeutics has raised $87.8M across 3 rounds on record. The most recent is a Series B of $27.0M announced in Feb 2025.

When did Auron Therapeutics last raise funding?

Auron Therapeutics' most recent funding round on record is a Series B of $27.0M, announced in Feb 2025.

Who founded Auron Therapeutics?

FundedIQ lists Kate Yen (Founder), Matthew Heiden (Founder) at Auron Therapeutics.

Where is Auron Therapeutics headquartered?

Auron Therapeutics is based in Wellesley, Massachusetts, United States.

How many employees does Auron Therapeutics have?

Auron Therapeutics is in the 1-10 employee band.

How does Auron Therapeutics' funding compare to other Biotechnology startups?

Auron Therapeutics' latest round of $27.0M is above the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's Auron Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Auron Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.